Ligand validation:5CTG

PE5: 3,6,9,12,15,18,21,24-OCTAOXAHEXACOSAN-1-OL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5CTG_PE5_B_301	35%	74%	0.215	0.925	0.73	0.3	-	-	5	0	89%	1
5CTG_PE5_A_301	4%	73%	0.38	0.771	0.82	0.26	1	-	0	0	89%	1
5CTH_PE5_C_301	0%	66%	0.611	0.591	0.92	0.39	1	-	0	0	89%	1
1WMA_PE5_A_310	89%	64%	0.08	0.957	0.71	0.66	-	-	1	0	100%	1
6QF2_PE5_A_418	72%	86%	0.128	0.952	0.53	0.19	-	-	0	0	100%	0.47
5ZRU_PE5_C_601	69%	74%	0.099	0.911	0.55	0.45	-	-	1	0	100%	1
4MUU_PE5_B_217	62%	72%	0.12	0.911	0.78	0.3	-	-	11	0	100%	0.53
9C1D_PE5_A_1108	59%	88%	0.129	0.91	0.34	0.34	-	-	7	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.